Lacosamide Extended-Release Tablet with Immediate Layer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current extended-release lacosamide formulations lack initial drug efficacy and exhibit variable dissolution profiles due to differing active ingredient contents, making them unsuitable for once-daily administration without compromising bioequivalence to immediate-release preparations.
Innovation Solution
A pharmaceutical composition comprising lacosamide with both an immediate-release and extended-release layer, utilizing a cellulose derivative and wax or wax-like lipid in specific weight ratios to maintain bioequivalence and consistent dissolution profiles across varying active ingredient contents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If an extended-release formulation is used to enable once-daily administration, then the duration of action is improved, but the initial drug efficacy deteriorates
Solution Approach 1:
The tablet is divided into two distinct layers: an immediate-release layer containing lacosamide for rapid absorption and initial efficacy, and an extended-release layer for sustained drug delivery over 24 hours. This segmentation allows both immediate and prolonged therapeutic effects to be achieved simultaneously.
Solution Approach 2:
The immediate-release layer is designed to release lacosamide rapidly upon administration, providing preliminary therapeutic action before the extended-release layer takes over. This ensures that the initial drug efficacy is maintained while the extended-release mechanism provides prolonged action.
2Adaptability or versatility
If the active ingredient content varies in extended-release formulations, then the adaptability is improved, but the dissolution profile consistency deteriorates
Solution Approach 1:
Different layers of the tablet have different functional qualities: the immediate-release layer is optimized for rapid dissolution to provide consistent initial drug levels, while the extended-release layer is optimized for controlled, sustained release. Each layer's composition and structure are specifically tailored to its local function, ensuring overall consistency despite varying total drug contents.
Solution Approach 2:
The tablet uses a composite structure combining immediate-release and extended-release layers with different material compositions. This composite approach allows the formulation to maintain consistent dissolution profiles across different strength variants by ensuring that each layer contributes predictably to the overall drug release pattern.
3Device complexity
If a single-layer extended-release tablet is used, then the device complexity is reduced, but the drug release control precision deteriorates
Solution Approach 1:
The tablet is segmented into two functional layers with distinct drug release characteristics. This segmentation enables precise control over the drug release profile, with the immediate-release layer providing rapid initial delivery and the extended-release layer providing sustained release, achieving high drug release control precision.
Solution Approach 2:
The tablet exhibits dynamic drug release behavior through its two-layer structure, transitioning from rapid release in the immediate-release layer to controlled sustained release in the extended-release layer. This dynamic release pattern allows precise control over the temporal distribution of drug delivery.
Data Source
AI summary
Disclosed is an extended-release lacosamide preparation which can be taken once a day. Also disclosed is a method for treating a subject with epilepsy including administering the extended-release lacosamide preparation once a day.